听力与言语-语言病理学

行为科学

医学伦理学

你正在浏览GENE THERAPY期刊下所有文献
  • Schwann cell targeting via intrasciatic injection of AAV8 as gene therapy strategy for peripheral nerve regeneration.

    abstract::Efficient transduction of the peripheral nervous system (PNS) is required for gene therapy of acquired and inherited neuropathies, neuromuscular diseases and for pain treatment. We have characterized the tropism and transduction efficiency of different adeno-associated vectors (AAV) pseudotypes after sciatic nerve inj...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2011.7

    authors: Homs J,Ariza L,Pagès G,Udina E,Navarro X,Chillón M,Bosch A

    更新日期:2011-06-01 00:00:00

  • Highly efficient multipotent differentiation of human periodontal ligament fibroblasts induced by combined BMP4 and hTERT gene transfer.

    abstract::Because periodontal ligament (PDL) cells are reported to contain progenitor or stem cell populations, they are considered a beneficial cell source for clinical periodontal regeneration. Both bone morphogenetic protein 4 (BMP4) and human telomerase reverse transcriptase (hTERT) have essential roles in the modulation of...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2010.158

    authors: Mi HW,Lee MC,Fu E,Chow LP,Lin CP

    更新日期:2011-05-01 00:00:00

  • VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson's disease.

    abstract::The umbilical cord provides a rich source of primitive mesenchymal stem cells (human umbilical cord mesenchymal stem cells (HUMSCs)), which have the potential for transplantation-based treatments of Parkinson's Disease (PD). Our pervious study indicated that adenovirus-associated virus-mediated intrastriatal delivery ...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2010.152

    authors: Xiong N,Zhang Z,Huang J,Chen C,Zhang Z,Jia M,Xiong J,Liu X,Wang F,Cao X,Liang Z,Sun S,Lin Z,Wang T

    更新日期:2011-04-01 00:00:00

  • Anti-inflammatory effect of MAPK phosphatase-1 local gene transfer in inflammatory bone loss.

    abstract::Alveolar bone loss associated with periodontal diseases is the result of osteoclastogenesis induced by bacterial pathogens. The mitogen-activated protein kinase (MAPK) phosphatase 1 (MKP-1) is a critical negative regulator of immune response as a key phosphatase capable of dephosphorylating activated MAPKs. In this st...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2010.139

    authors: Yu H,Li Q,Herbert B,Zinna R,Martin K,Junior CR,Kirkwood KL

    更新日期:2011-04-01 00:00:00

  • Transient expression of OCT4 is sufficient to allow human keratinocytes to change their differentiation pathway.

    abstract::In this study, we describe a simple system in which human keratinocytes can be redirected to an alternative differentiation pathway. We transiently transfected freshly isolated human skin keratinocytes with the single transcription factor OCT4. Within 2 days these cells displayed expression of endogenous embryonic gen...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2010.148

    authors: Racila D,Winter M,Said M,Tomanek-Chalkley A,Wiechert S,Eckert RL,Bickenbach JR

    更新日期:2011-03-01 00:00:00

  • Progress and prospects: oligonucleotide-directed gene modification in mouse embryonic stem cells: a route to therapeutic application.

    abstract::Gene targeting by single-stranded oligodeoxyribonucleotides (ssODNs) is a promising technique for introducing site-specific sequence alterations without affecting the genomic organization of the target locus. Here, we discuss the significant progress that has been made over the last 5 years in unraveling the mechanism...

    journal_title:Gene therapy

    pub_type: 杂志文章,评审

    doi:10.1038/gt.2010.161

    authors: Aarts M,te Riele H

    更新日期:2011-03-01 00:00:00

  • Validation of recombinant Sendai virus in a non-natural host model.

    abstract::We have previously shown that recombinant Sendai virus (SeV) vector, derived from murine parainfluenza virus, is one of the most efficient vectors for airway gene transfer. We have also shown that SeV-mediated transfection on second administration, although reduced by 60% when compared with levels achieved after a sin...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2010.131

    authors: Griesenbach U,McLachlan G,Owaki T,Somerton L,Shu T,Baker A,Tennant P,Gordon C,Vrettou C,Baker E,Collie DD,Hasegawa M,Alton EW

    更新日期:2011-02-01 00:00:00

  • CD28 cosignalling does not affect the activation threshold in a chimeric antigen receptor-redirected T-cell attack.

    abstract::Adoptive immunotherapy of cancer using chimeric antigen receptor (CAR)-engineered T cells with redirected specificity showed efficacy in recent trials. In preclinical models, 'second-generation' CARs with CD28 costimulatory domain in addition to CD3ζ performed superior in redirecting T-cell effector functions and surv...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2010.127

    authors: Chmielewski M,Hombach AA,Abken H

    更新日期:2011-01-01 00:00:00

  • Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution.

    abstract::Newly isolated serotypes of AAV readily cross the endothelial barrier to provide efficient transgene delivery throughout the body. However, tissue-specific expression is preferred in most experimental studies and gene therapy protocols. Previous efforts to restrict gene expression to the myocardium often relied on dir...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2010.105

    authors: Prasad KM,Xu Y,Yang Z,Acton ST,French BA

    更新日期:2011-01-01 00:00:00

  • Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells.

    abstract::Glioblastoma multiforme (GBM) is one of the most formidable brain tumors with a mean survival period of approximately 12 months. To date, a combination of radiotherapy and chemotherapy with an oral alkylating agent, temozolomide (TMZ), has been used as first-line therapy for glioma. However, the efficacy of chemothera...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2010.88

    authors: Kato T,Natsume A,Toda H,Iwamizu H,Sugita T,Hachisu R,Watanabe R,Yuki K,Motomura K,Bankiewicz K,Wakabayashi T

    更新日期:2010-11-01 00:00:00

  • Regeneration of pancreatic islets in vivo by ultrasound-targeted gene therapy.

    abstract::This study uses a novel approach to gene therapy in which plasmid DNA is targeted to the pancreas in vivo using ultrasound-targeted microbubble destruction (UTMD) to achieve islet regeneration. Intravenous microbubbles carrying plasmids are destroyed within the pancreatic microcirculation by ultrasound, achieving loca...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2010.85

    authors: Chen S,Shimoda M,Wang MY,Ding J,Noguchi H,Matsumoto S,Grayburn PA

    更新日期:2010-11-01 00:00:00

  • Local arterial nanoparticle delivery of siRNA for NOX2 knockdown to prevent restenosis in an atherosclerotic rat model.

    abstract::Both atherosclerosis and arterial interventions induce oxidative stress mediated in part by nicotinamide adenine dinucleotide phosphate (NADPH) oxidases that have a pivotal role in the development of neointimal hyperplasia and restenosis. For small interfering RNA (siRNA) targeting of the NOX2 (Cybb) component of the ...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2010.69

    authors: Li JM,Newburger PE,Gounis MJ,Dargon P,Zhang X,Messina LM

    更新日期:2010-10-01 00:00:00

  • Adoptive immunotherapy with genetically engineered T cells: modification of the IgG1 Fc 'spacer' domain in the extracellular moiety of chimeric antigen receptors avoids 'off-target' activation and unintended initiation of an innate immune response.

    abstract::Chimeric antigen receptors (CARs, immunoreceptors) are frequently used to redirect T cells with pre-defined specificity, in particular towards tumour cells for use in adoptive immunotherapy of malignant diseases. Specific targeting is mediated by an extracellularly located antibody-derived binding domain, which is joi...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2010.91

    authors: Hombach A,Hombach AA,Abken H

    更新日期:2010-10-01 00:00:00

  • Cell-based osteoprotegerin therapy for debris-induced aseptic prosthetic loosening on a murine model.

    abstract::Exogenous osteoprotegerin (OPG) gene modification appears a therapeutic strategy for osteolytic aseptic loosening. The feasibility and efficacy of a cell-based OPG gene delivery approach were investigated using a murine model of knee prosthesis failure. A titanium pin was implanted into mouse proximal tibia to mimic a...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2010.64

    authors: Zhang L,Jia TH,Chong AC,Bai L,Yu H,Gong W,Wooley PH,Yang SY

    更新日期:2010-10-01 00:00:00

  • Development of a nonintegrating Rev-dependent lentiviral vector carrying diphtheria toxin A chain and human TRAF6 to target HIV reservoirs.

    abstract::Persistence of human immunodeficiency virus (HIV) despite highly active antiretroviral therapy (HAART) is a lasting challenge to virus eradication. To develop a strategy complementary to HAART, we constructed a series of Rev-dependent lentiviral vectors carrying diphtheria toxin A chain (DT-A) and its attenuated mutan...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2010.53

    authors: Wang Z,Tang Z,Zheng Y,Yu D,Spear M,Iyer SR,Bishop B,Wu Y

    更新日期:2010-09-01 00:00:00

  • Heart-targeted adeno-associated viral vectors selected by in vivo biopanning of a random viral display peptide library.

    abstract::Selection of targeted vectors from virus display peptide libraries is a versatile and efficient approach to improve vector specificity and efficiency. This strategy has been used to target various cell types in vitro. Here, we report the screening of an adeno-associated virus type 2 (AAV2) display peptide library in v...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2010.44

    authors: Ying Y,Müller OJ,Goehringer C,Leuchs B,Trepel M,Katus HA,Kleinschmidt JA

    更新日期:2010-08-01 00:00:00

  • Locoregional intravascular viral therapy of cancer: precision guidance for Paris's arrow?

    abstract::Viral therapy of cancer includes strategies such as viral transduction of tumour cells with 'suicide genes', using viral infection to trigger immune-mediated tumour cell death and using oncolytic viruses for their direct anti-tumour action. However, problems still remain in terms of adequate viral delivery to tumours....

    journal_title:Gene therapy

    pub_type: 杂志文章,评审

    doi:10.1038/gt.2010.48

    authors: Pencavel T,Seth R,Hayes A,Melcher A,Pandha H,Vile R,Harrington KJ

    更新日期:2010-08-01 00:00:00

  • Gene doping detection: evaluation of approach for direct detection of gene transfer using erythropoietin as a model system.

    abstract::As clinical gene therapy has progressed toward realizing its potential, concern over misuse of the technology to enhance performance in athletes is growing. Although 'gene doping' is banned by the World Anti-Doping Agency, its detection remains a major challenge. In this study, we developed a methodology for direct de...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2010.49

    authors: Baoutina A,Coldham T,Bains GS,Emslie KR

    更新日期:2010-08-01 00:00:00

  • Generation of human TRIM5alpha mutants with high HIV-1 restriction activity.

    abstract::Rhesus macaque tripartite motif (TRIM)5alpha potently inhibits early stages of human immunodeficiency virus (HIV)-1 replication, while the human orthologue has little effect on this virus. We used PCR-based random mutagenesis to construct a large library of human TRIM5alpha variants containing mutations in the PRYSPRY...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2010.40

    authors: Pham QT,Bouchard A,Grütter MG,Berthoux L

    更新日期:2010-07-01 00:00:00

  • Self-complementary AAV-mediated gene therapy restores cone function and prevents cone degeneration in two models of Rpe65 deficiency.

    abstract::To test whether fast-acting, self-complimentary (sc), adeno-associated virus-mediated RPE65 expression prevents cone degeneration and/or restores cone function, we studied two mouse lines: the Rpe65-deficient rd12 mouse and the Rpe65-deficient, rhodopsin null ('that is, cone function-only') Rpe65(-/-)::Rho(-/-) mouse....

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2010.29

    authors: Pang J,Boye SE,Lei B,Boye SL,Everhart D,Ryals R,Umino Y,Rohrer B,Alexander J,Li J,Dai X,Li Q,Chang B,Barlow R,Hauswirth WW

    更新日期:2010-07-01 00:00:00

  • Articular cartilage repair by genetically modified bone marrow aspirate in sheep.

    abstract::Bone marrow presents an attractive option for the treatment of articular cartilage defects as it is readily accessible, it contains mesenchymal progenitor cells that can undergo chondrogenic differentiation and, once coagulated, it provides a natural scaffold that contains the cells within the defect. This study was p...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2010.16

    authors: Ivkovic A,Pascher A,Hudetz D,Maticic D,Jelic M,Dickinson S,Loparic M,Haspl M,Windhager R,Pecina M

    更新日期:2010-06-01 00:00:00

  • Insulin expressed from endogenously active glucose-responsive EGR1 promoter in bone marrow mesenchymal stromal cells as diabetes therapy.

    abstract::Advances in islet transplantation have encouraged efforts to create alternative insulin-secreting cells that overcome limitations associated with current therapies. We have recently demonstrated durable correction of murine and porcine diabetes by syngeneic and autologous implantation, respectively, of primary hepatoc...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2010.12

    authors: Chen NK,Tan SY,Udolph G,Kon OL

    更新日期:2010-05-01 00:00:00

  • Technical requirements for effective regional hydrodynamic gene delivery to the left lateral lobe of the rat liver.

    abstract::Hydrodynamic gene delivery to the liver is an attractive approach for clinical liver gene therapy, but critical aspects of technique remain uncertain. There has not been to date any report of high levels of hydrodynamic gene delivery to the liver, except in rodents. Regional hydrodynamic delivery to individual lobes/s...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2009.167

    authors: Sawyer GJ,Zhang X,Fabre JW

    更新日期:2010-04-01 00:00:00

  • Electroporation-mediated delivery of a naked DNA plasmid expressing VEGF to the porcine heart enhances protein expression.

    abstract::Gene therapy is an attractive method for the treatment of cardiovascular disease. However, using current strategies, induction of gene expression at therapeutic levels is often inefficient. In this study, we show a novel electroporation (EP) method to enhance the delivery of a plasmid expressing an angiogenic growth f...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2009.153

    authors: Marshall WG Jr,Boone BA,Burgos JD,Gografe SI,Baldwin MK,Danielson ML,Larson MJ,Caretto DR,Cruz Y,Ferraro B,Heller LC,Ugen KE,Jaroszeski MJ,Heller R

    更新日期:2010-03-01 00:00:00

  • DsAAV8-mediated expression of glucagon-like peptide-1 in pancreatic beta-cells ameliorates streptozotocin-induced diabetes.

    abstract::Glucagon-like peptide-1 (GLP-1) is an incretin hormone that performs a wide array of well-characterized antidiabetic actions, including stimulation of glucose-dependent insulin secretion, upregulation of insulin gene expression and improvements in beta-cell survival. GLP-1-receptor agonists have been developed for tre...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2009.143

    authors: Riedel MJ,Gaddy DF,Asadi A,Robbins PD,Kieffer TJ

    更新日期:2010-02-01 00:00:00

  • Effect of decorin on overcoming the extracellular matrix barrier for oncolytic virotherapy.

    abstract::The pressing challenge for contemporary gene therapy is to deliver enough therapeutic genes to enough cancer cells in vivo. With the aim of improving viral distribution and tumor penetration, we explored the use of decorin to enhance viral spreading and tumor tissue penetration. We generated decorin-expressing replica...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2009.142

    authors: Choi IK,Lee YS,Yoo JY,Yoon AR,Kim H,Kim DS,Seidler DG,Kim JH,Yun CO

    更新日期:2010-02-01 00:00:00

  • Single-cycle viral gene expression, rather than progressive replication and oncolysis, is required for VSV therapy of B16 melanoma.

    abstract::A fully intact immune system would be expected to hinder the efficacy of oncolytic virotherapy by inhibiting viral replication. Simultaneously, however, it may also enhance antitumor therapy through initiation of proinflammatory, antiviral cytokine responses at the tumor site. The aim of this study was to investigate ...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2009.161

    authors: Galivo F,Diaz RM,Wongthida P,Thompson J,Kottke T,Barber G,Melcher A,Vile R

    更新日期:2010-02-01 00:00:00

  • PDGF-B gene therapy accelerates bone engineering and oral implant osseointegration.

    abstract::Platelet-derived growth factor-BB (PDGF-BB) stimulates repair of healing-impaired chronic wounds such as diabetic ulcers and periodontal lesions. However, limitations in predictability of tissue regeneration occur due, in part, to transient growth factor bioavailability in vivo. Here, we report that gene delivery of P...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2009.117

    authors: Chang PC,Seol YJ,Cirelli JA,Pellegrini G,Jin Q,Franco LM,Goldstein SA,Chandler LA,Sosnowski B,Giannobile WV

    更新日期:2010-01-01 00:00:00

  • Retroviral vector integration in post-transplant hematopoiesis in mice conditioned with either submyeloablative or ablative irradiation.

    abstract::X-linked chronic granulomatous disease (X-CGD) is an inherited immunodeficiency with absent phagocyte NADPH-oxidase activity caused by defects in the gene-encoding gp91(phox). Here, we evaluated strategies for less intensive conditioning for gene therapy of genetic blood disorders without selective advantage for gene ...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2009.96

    authors: Sadat MA,Dirscherl S,Sastry L,Dantzer J,Pech N,Griffin S,Hawkins T,Zhao Y,Barese CN,Cross S,Orazi A,An C,Goebel WS,Yoder MC,Li X,Grez M,Cornetta K,Mooney SD,Dinauer MC

    更新日期:2009-12-01 00:00:00

  • Efficient delivery of angiostatin K1-5 into tumors following insertion of an NGR peptide into adenovirus capsid.

    abstract::Adenovirus (Ad)-mediated delivery of anti-angiogenic molecules into tumors constitutes an appealing approach for growth inhibition. However, lack of expression on tumors of Ad receptors leads to weak tumor transduction. Therefore, to provide Ad with a new entry pathway into tumors, an NGR peptide was inserted into eit...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2009.97

    authors: Jullienne B,Vigant F,Muth E,Chaligné R,Bouquet C,Giraudier S,Perricaudet M,Benihoud K

    更新日期:2009-12-01 00:00:00

  • Delivering multiple gene products in the brain from a single adeno-associated virus vector.

    abstract::For certain gene therapy applications, the simultaneous delivery of multiple genes would allow for novel therapies. In the case of adeno-associated virus (AAV) vectors, the limited packaging capacity greatly restricts current methods of carrying multiple transgene cassettes. To address this issue, a recombinant AAV (r...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2009.106

    authors: Foti SB,Samulski RJ,McCown TJ

    更新日期:2009-11-01 00:00:00

  • Engineering ligand-responsive gene-control elements: lessons learned from natural riboswitches.

    abstract::In the last two decades, remarkable advances have been made in the development of technologies used to engineer new aptamers and ribozymes. This has encouraged interest among researchers who seek to create new types of gene-control systems that can be made to respond specifically to small-molecule signals. Validation ...

    journal_title:Gene therapy

    pub_type: 杂志文章,评审

    doi:10.1038/gt.2009.81

    authors: Link KH,Breaker RR

    更新日期:2009-10-01 00:00:00

  • PML has a predictive role in tumor cell permissiveness to interferon-sensitive oncolytic viruses.

    abstract::The oncotropic phenotypes of several viruses correlate with tumor-associated deficiencies within interferon (IFN) signaling pathways. This observation formed the conceptual basis for developing oncolytic viruses deleted for viral proteins that inhibit the host IFN-dependent antiviral response, such as herpes simplex v...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2009.68

    authors: Sobol PT,Hummel JL,Rodrigues RM,Mossman KL

    更新日期:2009-09-01 00:00:00

  • Chitosan-plasmid nanoparticle formulations for IM and SC delivery of recombinant FGF-2 and PDGF-BB or generation of antibodies.

    abstract::Growth factor therapy is an emerging treatment modality that enhances tissue vascularization, promotes healing and regeneration and can treat a variety of inflammatory diseases. Both recombinant human growth factor proteins and their gene therapy are in human clinical trials to heal chronic wounds. As platelet-derived...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2009.60

    authors: Jean M,Smaoui F,Lavertu M,Méthot S,Bouhdoud L,Buschmann MD,Merzouki A

    更新日期:2009-09-01 00:00:00

  • Intravitreal delivery of AAV8 retinoschisin results in cell type-specific gene expression and retinal rescue in the Rs1-KO mouse.

    abstract::X-linked juvenile retinoschisis (XLRS) is a neurodevelopmental abnormality caused by retinoschisin gene mutations. XLRS is characterized by splitting through the retinal layers and impaired synaptic transmission of visual signals resulting in impaired acuity and a propensity to retinal detachment. Several groups have ...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2009.61

    authors: Park TK,Wu Z,Kjellstrom S,Zeng Y,Bush RA,Sieving PA,Colosi P

    更新日期:2009-07-01 00:00:00

  • Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV.

    abstract::Choroidal neovascularization (CNV) leads to loss of vision in age-related macular degeneration (AMD), the leading cause of blindness in adult population over 50 years old. In this study, we developed intravenously administered, nanoparticulate, targeted nonviral retinal gene delivery systems for the management of CNV....

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2008.185

    authors: Singh SR,Grossniklaus HE,Kang SJ,Edelhauser HF,Ambati BK,Kompella UB

    更新日期:2009-05-01 00:00:00

  • Gene therapy for pancreatitis pain.

    abstract::Pancreatic cancer and chronic pancreatitis are clinical syndromes associated with severe pain that is difficult to manage. Thus, seeking additional pain reduction therapies is warranted. Excessive alcohol consumption over an extended period of time is the primary causal agent in pancreatitis. The efficacy of a replica...

    journal_title:Gene therapy

    pub_type: 杂志文章,评审

    doi:10.1038/gt.2009.27

    authors: Westlund KN

    更新日期:2009-04-01 00:00:00

  • Co-expression of p21(Waf1/Cip1) in adenovirus vectors improves expression of a second transgene.

    abstract::First-generation adenoviral (Ad) vectors are frequently used vectors for experimental and clinical gene transfer. Earlier it has been shown that parallel overexpression of the cell cycle regulator p21(Waf1/Cip1) (p21) or antiapoptotic bcl-2 from a second vector reduces cytotoxicity and improves transgene expression. H...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2009.2

    authors: Schumacher A,Horvat S,Woischwill C,Wolff G,Witt C

    更新日期:2009-04-01 00:00:00

  • Human adipose tissue-derived mesenchymal stromal cells as vehicles for tumor bystander effect: a model based on bioluminescence imaging.

    abstract::Human adipose tissue mesenchymal stromal cells (AMSCs) share common traits, including similar differentiation potential and cell surface markers, with their bone marrow counterparts. Owing to their general availability, higher abundance and ease of isolation AMSCs may be convenient autologous delivery vehicles for loc...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2008.176

    authors: Vilalta M,Dégano IR,Bagó J,Aguilar E,Gambhir SS,Rubio N,Blanco J

    更新日期:2009-04-01 00:00:00

  • An adenoviral vector-based mucosal vaccine is effective in protection against botulism.

    abstract::A replication-incompetent adenoviral vector encoding the heavy chain C-fragment (H(C)50) of botulinum neurotoxin type C (BoNT/C) was evaluated as a mucosal vaccine against botulism in a mouse model. Single intranasal inoculation of the adenoviral vector elicited a high level of H(C)50-specific IgG, IgG1 and IgG2a in s...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2008.181

    authors: Xu Q,Pichichero ME,Simpson LL,Elias M,Smith LA,Zeng M

    更新日期:2009-03-01 00:00:00

403 条记录 3/11 页 « 1234567891011 »